Download video

The IMpassion130 Trial in Metastatic Triple-Negative Breast Cancer

167 views

Targeted Oncology

4 years ago

The IMpassion130 Trial in Metastatic Triple-Negative Breast Cancer

The IMpassion130 Trial in Metastatic Triple-Negative Breast Cancer

IMpassion130 Trial: OS Updates in Metastatic TNBC
7:19
IMpassion130 Trial: OS Updates in Metastatic TNBC
by OncLive
Results from the IMpassion130 trial for triple-negative breast cancer
4:53
Results from the IMpassion130 trial for triple-negative breast cancer
by ecancer
IMpassion130 Trial Data on PD-L1+ Tumors in TNBC
6:56
IMpassion130 Trial Data on PD-L1+ Tumors in TNBC
by OncLive
Chemoimmunotherapy in TNBC: The IMpassion130 Trial
8:42
Chemoimmunotherapy in TNBC: The IMpassion130 Trial
by OncLive
Results from the IMpassion 130 trial treating metastatic breast cancer
4:56
Results from the IMpassion 130 trial treating metastatic breast cancer
by ecancer
IMpassion130: Design and Preliminary Efficacy
2:51
IMpassion130: Design and Preliminary Efficacy
by OncLive
New vaccine designed to target triple-negative breast cancer
3:58
New vaccine designed to target triple-negative breast cancer
by FOX 11 Los Angeles
IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer
5:59
IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer
by ecancer
IMpassion130 Data Demonstrate Clinical Benefit for Immunotherapy in Metastatic TNBC
0:59
IMpassion130 Data Demonstrate Clinical Benefit for Immunotherapy in Metastatic TNBC
by Targeted Oncology
IMpassion130 Trial Data on PD-L1+ Tumors in TNBC
6:54
IMpassion130 Trial Data on PD-L1+ Tumors in TNBC
by AJMCtv
IMpassion130: immunotherapy for TNBC
2:30
IMpassion130: immunotherapy for TNBC
by VJOncology
The IMpassion130 Study in Metastatic TNBC
4:27
The IMpassion130 Study in Metastatic TNBC
by Targeted Oncology
TNBC: Updated Efficacy Results From IMpassion130
4:47
TNBC: Updated Efficacy Results From IMpassion130
by OncLive
I-O in TNBC: IMpassion130 Trial Design and Results
4:33
I-O in TNBC: IMpassion130 Trial Design and Results
by OncLive
Immunotherapy for TNBC: IMpassion130 \& KEYNOTE-355
4:11
Immunotherapy for TNBC: IMpassion130 \& KEYNOTE-355
by VJOncology
Dr. Rugo on Takeaways From the IMpassion130 Trial in TNBC
1:39
Dr. Rugo on Takeaways From the IMpassion130 Trial in TNBC
by OncLive
Study of Carboplatin plus Nivolumab in Metastatic Triple-Negative Breast Cancer
7:40
Study of Carboplatin plus Nivolumab in Metastatic Triple-Negative Breast Cancer
by Dana-Farber Cancer Institute
The importance of a biomarker-directed approach in triple-negative breast cancer
1:14
The importance of a biomarker-directed approach in triple-negative breast cancer
by VJOncology
Applying IMpassion130 Data to TNBC Management
2:33
Applying IMpassion130 Data to TNBC Management
by OncLive
IMpassion130 study: improvement in OS and PFS for IIT and PD-L1+ populations with mTNBC
2:52
IMpassion130 study: improvement in OS and PFS for IIT and PD-L1+ populations with mTNBC
by VJOncology